The Harbert 6Beacon Strategy (“6Beacon”) is an absolute return investment strategy predominantly focused on the public markets. Based in Boston, 6Beacon specializes in investing in companies that are nearing a major capital event in their lifecycle. Through longstanding partnerships with management teams that often start well before a company considers publicly listing, 6Beacon endeavors to be a source of diversified and flexible capital that can address a multitude of fundraising needs along a company’s journey.
Prior to co-founding 6Beacon Capital, Jamison served as an Associate Portfolio Manager at Crestline Investors, assisting with the oversight of a global equity capital markets focused portfolio. Prior to his experience at Crestline, Mr. Yaffa worked at Balyasny Asset Management, as a syndicate trader assisting in the global capital markets process and aiding in the execution of the firm’s equity options portfolio. He began his career as an investment banker at UBS. Mr. Yaffa graduated from the University of Connecticut with a B.A in Economics.
jyaffa@harbert.netPrior to co-founding 6Beacon Capital, David worked at Balyasny Asset Management as a Director of Capital Markets. Mr. Donohue started his career at Raptor Capital Management on the trading desk. David graduated from the University of Notre Dame with a B.A. in Finance. He was a member and captain of the soccer team.
ddonohue@harbert.netPrior to joining Harbert 6Beacon, Dr. Waksal completed a fellowship in hematology and oncology at The Mount Sinai Hospital, a residency in internal medicine at Weill Cornell Medical College, and served as chief resident at Memorial Sloan Kettering Cancer Center. He earned his MD at Tufts University School of Medicine and graduated magna cum laude from Vanderbilt University with a B.A. in economics and chemistry. He is board-certified in oncology and internal medicine. Dr. Waksal has designed and led numerous clinical trials and published in top tier journals including Blood and Nature-Leukemia. Leveraging his scientific and clinical expertise, he leads our investment efforts in the biotech and healthcare space.
jwaksal@harbert.netPrior to joining Harbert 6Beacon, Lucas began his career at Eaton Vance, working on several different fund strategies while primarily investing in technology companies. Post Eaton Vance, Lucas joined Putnam covering SMID-cap software and internet companies, while also working on the firm’s internal L/S TMT fund. He helped manage the firm’s private technology investments and evaluated new opportunities. Lucas spent a significant portion of his time getting to know companies in the private markets and during their IPO process. Most recently, Lucas worked on a L/S TMT hedge fund at Wellington Management where he was responsible for the software and internet sleeves of the fund. Lucas graduated from Boston College with a degree in Economics and Political Science.
llints@harbert.netContact:
Jack Bryant
jbryant@harbert.net
205.987.5500